Trevi Therapeutics Inc. (TRVI)
Market Closed
9 Dec, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
12. 98
-0.49
-3.64%
$
1.69B Market Cap
- P/E Ratio
0% Div Yield
1,836,464 Volume
-0.39 Eps
$ 13.47
Previous Close Day Range
12.85 13.66
Year Range
2.36 14
Want to track TRVI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| TRVI Trevi Therapeutics Inc. 13 Nov 2025 | | - | - |
| TRVI Trevi Therapeutics Inc. 5 Nov 2025 | | - | - |
| TRVI Trevi Therapeutics Inc. 4 Nov 2025 | | - | - |
| TRVI Trevi Therapeutics Inc. 7 Aug 2025 | | - | - |
| TRVI Trevi Therapeutics Inc. 5 May 2025 | | - | - |
| TRVI Trevi Therapeutics Inc. 18 Mar 2025 | | - | - |
| TRVI Trevi Therapeutics Inc. 7 Nov 2024 | | - | - |
| TRVI Trevi Therapeutics Inc. 8 Aug 2024 | | - | - |
| TRVI Trevi Therapeutics Inc. 13 Jun 2024 | | - | - |
| TRVI Trevi Therapeutics Inc. 14 Mar 2024 | | - | - |
| TRVI Trevi Therapeutics Inc. 8 Nov 2023 | | - | - |
TRVI Earnings Reports FAQ
What is the earnings per share (EPS) for TRVI?
The current EPS is -0.39.
What is the company's earnings growth rate?
Trevi Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Trevi Therapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Trevi Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for TRVI at this time, as Trevi Therapeutics Inc has no recent EPS data to calculate it.
2025 © Marketlog. All Rights Reserved.
